News & Analysis on Clinical Trial Services & Contract Research And Development
US researchers have discovered a specific pattern of gene expression linked to multiple-drug resistance of leukaemia cells is giving unique insights into why standard therapies fail to cure some children with acute lymphoblastic leukaemia (ALL). The...
Bruker Daltonics introduces a new system for clinical proteomics and peptide/protein biomarker discovery and validation, aimed at cancer research and other clinical and diagnostics research laboratories engaged in biomarker discovery across a range of...
The US Supreme Court's decision as to how much a patent can restrict research conducted by another company is a question that is certain to affect the way innovative new drugs are researched and developed.
Canadian researchers have a developed a new chemical reaction that could greatly accelerate pharmaceutical production, while also cutting costs and toxic by-products.
Researchers at Harvard University in the US have developed a new way of synthesising tetracyclines, potentially opening up avenues to the development of new drugs in this valuable antibiotic class, writes Phil Taylor.
SkyePharma will shortly sign up a marketing partner for its improved formulation of the local anaesthetic bupivacaine, a product which the UK-based drug delivery company says is one of the most important products in its pipeline.
US researchers have developed a new approach to fighting cancer, which uses nanoscale particles that can detect and destroy cancerous cells. This ability differentiates it from current molecular imaging approaches, which only detect the cancer but...